Regeneron Pharmaceuticals Correlations

Stocks . USA . 
Stock . Regeneron Pharmaceuticals
REGN Stock  USD 828.42  3.94  0.48%   
The current 90-days correlation between Regeneron Pharmaceuticals and Unicycive Therapeutics is -0.08 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regeneron Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regeneron Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Regeneron Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Regeneron Pharmaceuticals and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.

Moving together with Regeneron Stock

  0.76ME 23Andme HoldingPairCorr
  0.79VALN Valneva SE ADRPairCorr
  0.76VCNX Vaccinex Earnings Call TodayPairCorr
  0.65DRMA Dermata TherapeuticsPairCorr
  0.7DTIL Precision BioSciencesPairCorr
  0.82VINC Vincerx Pharma Earnings Call TomorrowPairCorr
  0.81DYAI Dyadic InternationalPairCorr
  0.61VNDA Vanda PharmaceuticalsPairCorr
  0.62VTGN VistaGen TherapeuticsPairCorr

Moving against Regeneron Stock

  0.83DRUG Bright Minds BiosciencesPairCorr
  0.69VERA Vera TherapeuticsPairCorr
  0.66VCYT VeracytePairCorr
  0.59DMAC DiaMedica Therapeutics Earnings Call TodayPairCorr
  0.44DSGN Design Therapeutics Earnings Call TodayPairCorr
  0.37DNLI Denali TherapeuticsPairCorr
  0.35VERV Verve TherapeuticsPairCorr
  0.91VSTM Verastem Buyout TrendPairCorr
  0.87VRNA Verona Pharma PLCPairCorr
  0.76VRDN Viridian Therapeutics Earnings Call TodayPairCorr
  0.62SABSW SAB BiotherapeuticsPairCorr
  0.52VKTX Viking TherapeuticsPairCorr
  0.45VIGL Vigil NeurosciencePairCorr
  0.38KTTAW Pasithea TherapeuticsPairCorr
  0.36DVAX Dynavax Technologies Buyout TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Regeneron Stock performing well and Regeneron Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Regeneron Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Regeneron Pharmaceuticals Corporate Management

Patrice GiloolySenior OperationsProfile
Andrew MurphyExecutive ResearchProfile
Melissa LoznerSenior OfficerProfile
Christopher CPAHead FinanceProfile
Ryan CroweSenior AnalysisProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY